Where does Amgen Research (MUNICH) GMBH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Amgen Research (MUNICH) GMBH ranks #5,138 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Amgen Research (MUNICH) GMBH hold?

Amgen Research (MUNICH) GMBH holds 67 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is Amgen Research (MUNICH) GMBH's Innovation Score?

Amgen Research (MUNICH) GMBH has an Innovation Score of 40.3 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Amgen Research (MUNICH) GMBH focus on?

Amgen Research (MUNICH) GMBH's top technology area is C07K (Peptides) with 66 patents, ranking #125 of 3,615 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Amgen Research (MUNICH) GMBH's patent grant rate increasing or decreasing?

Amgen Research (MUNICH) GMBH's recent grant velocity is +15% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Amgen Research (MUNICH) GMBH's patents?

Amgen Research (MUNICH) GMBH's patents average 18.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Amgen Research (MUNICH) GMBH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Amgen Research (MUNICH) GMBH

USPTO PatentsView assignee record - 67 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Amgen ranks #5,138 of 49,997 tracked US assignees by granted-patent volume, with 67 patents across 6 technology areas.

#5,138
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.3/100): 18.0
avg claims per patent: +15%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5138 · Foreign Corporation #5,138 · 67 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 67 grants
UPPER-Q #5,138/49,997
PHOTO-FINISH AAC Optics (Suzhou)
CPC-NARROW C07K · 6 areas
INNOV-PAR 40.3/100
CLAIMS-RICH 18.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +15% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AAC Optics (Suzhou) Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Amgen Research… · this assignee

40
Dorco · near

40
Össur Iceland ehf · near

40
Paul Hartmann · near

40
Silgan White Cap · near

40
3D Lighting… · lowest

7

What this shows Amgen's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Amgen's grants concentrate

Amgen Research (MUNICH) GMBH is a focused PatentsView assignee: 6 CPC subclasses with 98.5% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (8 grants) versus a trough of 4 in 2015. By volume, Amgen sits between AAC Optics (Suzhou) Co., Ltd. and Ancestry.com Operations Inc..

Amgen's three-year grant acceleration

Amgen Research (MUNICH) GMBH shows 17 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

AAC Optics (Suzho…

67
Academisch Zieken…

67
Adey Holdings (20…

67
Agfa Healthcare

67
Amini Innovation

67
Areva NP

67
Adient US

67
Ancestry com Oper…

67
Amgen Research (M… ◀

67

What this shows Amgen holds 67 patents at rank #5,137, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Amgen

By rank, the assignees closest to #5,137 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Amgen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Amgen, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Amgen ranks #125 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Silgan White Cap LLC 40 Össur Iceland ehf 40 Paul Hartmann AG 40 Dorco Co., Ltd. 40

Similar claim depth

Nearest assignees by average claims per patent (18.0 here).

Beijing Volcano Engine Technology Co., Ltd. 18.0 avg Immunomedics, Inc. 18.0 avg Continuous Composites Inc. 18.0 avg Joyson Safety Systems Acquisition LLC 18.0 avg

Amgen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Amgen Research (MUNICH) GMBH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	6.0%
2016	6	9.0%
2017	6	9.0%
2018	7	10.4%
2019	4	6.0%
2020	6	9.0%
2021	8	11.9%
2022	6	9.0%
2023	6	9.0%
2024	5	7.5%
2025partial year	9	13.4%

Which technologies does Amgen Research (MUNICH) GMBH patent most?

C07K - Peptides 66

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 60

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 60

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 10

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

B01D - Separation 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#5,138

of 49,997 tracked assignees

Innovation Score

40.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Amgen Research (MUNICH) GMBH's patent record in context - here's where to go next.

Amgen Research (MUNICH) GMBH's lead technology class is C07K (Peptides), 98.5% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #5,138 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Amgen Research (MUNICH) GMBH against AAC Optics (Suzhou) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.